NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

NRIX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/24

08:03 am

nrix

Nurix Therapeutics (NRIX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.

Low Report

Nurix Therapeutics (NRIX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.

Report

1/29

11:02 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

11:02 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

10:46 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

09:08 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

09:08 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

08:43 am

nrix

Nurix Therapeutics (NASDAQ:NRIX) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.

Low Report

Nurix Therapeutics (NASDAQ:NRIX) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.

Report

1/29

08:27 am

nrix

Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $30.00 price target on the stock.

Low Report

Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $30.00 price target on the stock.

Report

1/29

08:23 am

nrix

Rating for NRIX

Low Report

Rating for NRIX

Report

1/29

08:03 am

nrix

Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.

Medium Report

Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.

Report

1/29

07:03 am

nrix

Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Low Report

Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Report

1/29

06:23 am

nrix

Rating for NRIX

Medium Report

Rating for NRIX

Report

1/29

06:23 am

nrix

Rating for NRIX

Medium Report

Rating for NRIX

Report

1/8

07:08 am

nrix

Rating for NRIX

Medium Report

Rating for NRIX

Report

1/8

07:08 am

nrix

Rating for NRIX

Medium Report

Rating for NRIX

Report

1/8

05:02 am

nrix

Nurix Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley

Medium Report

Nurix Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley

Report

1/8

05:02 am

nrix

Nurix Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley

Medium Report

Nurix Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.